Immunic is cleared to start a phase 2 trial of its IMU-838 in COVID-19. Soleno receives a setback. Opko records positive data for somatrogon.
Swiss National Bank grew its holdings in Opko Health Inc. (NASDAQ:OPK) by 9.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor
Following last October’s announcement of successful results of the global Phase 3 study of once-weekly somatrogon, an investigational agent for the treatment of pediatric growth hormone deficiency (
Israel stocks higher at close of trade; TA 35 up 0.09%

Weekly CEO Buys Highlight: UPS, HP

02:50pm, Monday, 08'th Jun 2020
Details the CEO buys this past week for the following companies: United Parcel Service, B. Riley Financial, OPKO Health and HP Inc Continue reading...
NeoGenomics runs a network of cancer-testing laboratories across the US, Switzerland and Singapore. The company offers a unique combination of services and prod

Wall Street Breakfast: The Week Ahead

12:43pm, Sunday, 07'th Jun 2020
Welcome to Wall Street Brunch, our preview of stock market events for investors to watch during the upcoming week. You can also catch this article a day early b
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE